Xuemin Zhu
PhD
Researcher
Xuemin joined Health Economics Research Centre (HERC) in April 2023 as a researcher.
Her work focusses on the health economic analysis of StereoTactic radiotherapy for wet age-related macular degeneration and the psychometric assessment of health outcome measures such as EQ-5D, EQ-5D-Y, EQ-HWB and ASCOT in rare genetic diseases.
Prior to her current position, Xuemin worked as a research assistant at the Vanke School of Public Health, Tsinghua University. During her time there, she used health insurance data to evaluate the impacts of the pandemic and a long-term care insurance pilot on healthcare usage.
Xuemin completed her PhD in Health Economics from the University of Aberdeen, with a thesis exploring the role of physicians’ risk attitudes and personality traits on decision-making. She was awarded an MSc in Health Economics from the University of York with a thesis focusing on the role of time preference on time trade-off values. Xuemin obtained her BSc in International Economics and Trade (Medical direction) from the China Pharmaceutical University.
Xuemin’s research interests include economic evaluations and stated preference studies, policy evaluation and non-cognitive skills in decision-making.
Recent publications
Content validity, face validity and comprehensiveness of generic quality-of-life measures in adults and children with rare genetic conditions and their carers: a think aloud qualitative study.
Journal article
Bourke M. et al, (2026), Qual Life Res, 35
Stereotactic radiotherapy for neovascular age related macular degeneration: year 3 and 4 extended follow up results of a randomised, double masked, sham controlled, device trial (STAR).
Journal article
Jackson TL. et al, (2026), BMJ, 393
EQ-5D vision bolt-on in macular degeneration: Associations with visual measures and effect on utility differences and cost-effectiveness of stereotactic radiotherapy
Journal article
Zhu X. et al, (2026), Health and Quality of Life Outcomes
Stereotactic radiotherapy for nAMD: areas for improvement - Authors' reply.
Journal article
Jackson TL. et al, (2025), Lancet, 406, 26 - 27
Reduction in inpatient and severe condition visits for respiratory diseases during the COVID-19 pandemic in Wuhan, China
Journal article
Zhu X. et al, (2024), Global Transitions
